Rakesh Gulati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rakesh Gulati has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Christine Chmielewski
Department of Medicine, Thomas Jefferson University, 2228 South Broad Street, Philadelphia, PA 19145, USA
1 shared publication- Edward John Filippone
Division of Nephrology, Department of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University
1 shared publication - Eric Newman
Geisinger Health System Danville Pennsylvania
1 shared publication John L. Farber
Department of Pathology, Thomas Jefferson University, Philadelphia, PA 19107, USA
1 shared publication
Latest Publications
- Open Access
- 13 June 2013
- Published by Wiley in Case Reports in Transplantation
- Vol. 2013, 1-5
De NovoFibrillary Glomerulonephritis (FGN) in a Renal Transplant with Chronic Hepatitis C
Chronic hepatitis C viremia (HepC) has been associated with numerous renal manifestations both in native kidneys and in the setting of renal transplantation. Glomerulonephritis (GN) of the renal allograft in the setting of HepC most commonly manifests as type 1 membranoproliferative GN (MPGN), either representing recurrence of the original disease or arisingde novo. Other GNs were reported after transplantation in the patient with HepC including membranous nephropathy and thrombotic microangiopathy, as well as an enhanced susceptibility to transplant glomerulopathy. We describe the first case ofde novofibrillary GN in a renal transplant patient with HepC where the primary renal disease was biopsy proven type 1 MPGN. We discuss this relationship in detail.
- 13 June 2013
- Published by Wiley in Case Reports in Transplantation
- Vol. 2013, 1-5
Open AccessDe NovoFibrillary Glomerulonephritis (FGN) in a Renal Transplant with Chronic Hepatitis C
Chronic hepatitis C viremia (HepC) has been associated with numerous renal manifestations both in native kidneys and in the setting of renal transplantation. Glomerulonephritis (GN) of the renal allograft in the setting of HepC most commonly manifests as type 1 membranoproliferative GN (MPGN), either representing recurrence of the original disease or arisingde novo. Other GNs were reported after transplantation in the patient with HepC including membranous nephropathy and thrombotic microangiopathy, as well as an enhanced susceptibility to transplant glomerulopathy. We describe the first case ofde novofibrillary GN in a renal transplant patient with HepC where the primary renal disease was biopsy proven type 1 MPGN. We discuss this relationship in detail.